Smoking Abstinence and Response to Smoking Cues - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

October 3, 2006

Last Updated Date

October 3, 2008

Start Date ^†

July 2006

Current Primary Outcome Measures ^†

Original Primary Outcome Measures ^†

Change History

Complete list of historical versions of study NCT00385060 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Smoking Abstinence and Response to Smoking Cues

Official Title ^†

Brief Summary

Tobacco smokers who are willing to stop smoking for up to 35 days will be randomly assigned to abstain from all nicotine use for 7 to 35 days.

Participants will make brief daily visit to the study site to verify abstinence from smoking and participate in up to three cue-reactivity sessions. The cue-presentation task will involve visual, olfactory, and tactile cues. Participants will complete standardized mood questionnaires, and physiological responses will be measured.

Detailed Description

Study Phase

Phase I

Study Type ^†

Observational

Study Design ^†

Other, Prospective

Condition ^†

Tobacco Smoking

Intervention ^†

Study Arms / Comparison Groups

7-day smoking abstinence
14-day smoking abstinence
35-day smoking abstinence
35-day smoking abstinence (within group time evaluation)

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Recruiting

Enrollment ^†

420

Estimated Completion Date

July 2010

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

age 18 and over current tobacco smoker

Exclusion Criteria:

cognitive impairment medical or psychiatric conditions that would contraindicate participation

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Yes

Contacts ^††

Location Countries ^†

United States

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00385060

Responsible Party

Kenzie L. Preston, Ph.D., Principal Investigator, National Institute on Drug Abuse

Secondary IDs ^††

Study Sponsor ^†

National Institute on Drug Abuse (NIDA)

Collaborators ^††

Investigators ^†

Principal Investigator:

Harriet de Wit, PhD

University of Chicago

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

October 2008

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.